Breaking down the costs
Let’s take a closer look at what these costs actually include:
● Direct medical expenses: These comprise transfusions, medications, lab tests, and regular checkups.
● Hidden or indirect costs: Travel to and from hospitals, lost income from taking time off work, extra accommodation, and sometimes even the cost of withdrawing a child from school.
These aren’t just items on a bill—they’re real-life disruptions that can derail a family’s financial stability. It’s not uncommon for caregivers to pause their careers or sell off assets just to keep up with ongoing treatment needs.
What can be done?
This year’s World Thalassemia Day theme—“Empowering Patients, Building Stronger Systems”—sends a clear message. There needs to be a rethink on how families can get better support and systems can be strengthened.
Here are a few practical steps that could make a difference:
● Universal Health Coverage (UHC) should include thalassemia as part of its essential services, so patients aren’t left paying out-of-pocket.
● Iron chelation drugs and transfusions need to be made more affordable, possibly through government subsidies or negotiated pricing.
● Carrier screening and prenatal diagnostics should be scaled up, especially in high-risk communities.
● Public-private partnerships can help bring better infrastructure and resources to underserved areas.
● Telemedicine could ease the burden of travel and help connect patients with specialists from the comfort of their homes.
Countries like Iran, Maldives and Thailand have already made great strides through national-level screening and awareness programmes, dramatically reducing new cases. There’s a lot others can learn from their example.
A day to reflect—and act
World Thalassemia Day isn’t just about statistics or medical facts. It’s about the lives behind those numbers. It’s about the families who’ve had to choose between paying rent and buying medication, and the kids who’ve grown up in hospital rooms instead of playgrounds.
Despite the progress over the years, there is still much to do. Thalassemia is not just a health condition, but an economic issue that demands systemic change. Investing in prevention, supporting families, and building a more inclusive healthcare model, will signal real steps toward easing the burden.
(Dr Sharat Damodar is Senior Consultant, Clinical Lead, Director – Adult Haemato Oncology & BMT, Narayana Health City and Chairman – Oncology Collegium, Narayana Health Group)
